Dr Reddy's Laboratories on Friday reported a consolidated net profit of Rs 554 crore for the quarter ended March, down 28 per cent from Rs 764 crore in the same period of the previous fiscal.The company said selling, general and administrative (SG & A) expenses went up by 17 per cent to Rs 1,430 crore due to incremental costs after the integration of Wockhardt's acquired divisions and increased freight expenses.Consolidated revenues grew 7 per cent year-on-year to Rs 4,728 crore while R & D expenses comprised 8.7 per cent of revenues at Rs 409 crore.Earnings before interest, taxes, depreciation and amortisation (EBITDA) were up 13 per cent year-on-year during Q4 FY21 at Rs 1,133 crore.For the entire year (FY21), profit after tax totalled Rs 1,915 crore on revenues of Rs 18,972 crore.Co-Chairman and MD G V Prasad said the company continued to grow across all businesses, enhanced productivity and strengthened development pipeline."We are prioritising our efforts to launch ...
Indian Energy Exchange (IEX) witnessed 41 per cent increase in transaction revenue
IT firm Mphasis has reported a 10.2 per cent decline in its consolidated net profit to Rs 316.9 crore in the March 2021 quarter
The management said the domestic decorative business delivered a stellar performance, registering a 48 per cent volume growth in the quarter, led by robust growth in the premium and luxury product ran
The strong margins and cost synergies have augured well for EBITDA margin expansion of 270 basis points (bps) at 22 per cent during the quarter
Royal Enfield said it has decided to shut down its two manufacturing facilities between May 13-16 amid a second Covid wave
The total dividend payout on this account would be Rs 788 crore
Net sales of the company stood at Rs 27,874 crore in the period under review, up 43 per cent from the same period last year
The board of directors has recommended a dividend of Rs 33 per share for FY21.
This was helped by higher income
Consolidated total income up 13%; robust anti-diabetic sales, new product pipeline, expanded coverage of cardiologists support better numbers
In dollar terms, the revenue stood at $30.2 million, up 18 per cent year-on-year and 15.4 per cent sequentially
Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter, driven by robust sales across domestic and international markets
Airtel Africa said for the full year ended March 31, the reported revenue grew 14.2 per cent to $3,908 million
The company's revenue from operations in Q4 was up 43.5 per cent to Rs 6,651.4 crore from a year ago
Revenues from operations stood at Rs 2,146 crore, up 24.9% YOY and 17.7% over the previous quarter
Better procurement of raw materials and implementation of cost-saving projects over the last few months and the year assisted in bolstering the margins of the company in Q4FY21
IT company Sify Technologies posted over a six-fold jump in profit at Rs 90.4 crore for the March ended quarter due to rapid digital transformation of business amid COVID-19 pandemic.
In Q4FY21, the net interest income (NII) grew 75 per cent year-on-year (YoY) at Rs 275.70 crore as against Rs 157.54 crore in the year-ago quarter
The stock was trading at its lowest level since October 30, 2020, having corrected 34 per cent from its 52-week high level of Rs 430.25